Evidence Impact on Biologics Confidence for Psoriasis
Recruiting0 awards2 criteria
Winston-Salem, North Carolina
This trial will study whether patients are more confident in the potential success of biologic medications in treating their psoriasis after being presented with clinical trial evidence, anecdotal evidence, or both.
SFA002 + Supplements for Psoriasis
Recruiting1 awardPhase 1
Fargo, North Dakota
This trial is testing a new drug called SFA004 on people with mild to moderate chronic plaque psoriasis to see if it is safe and effective. The study will last several months, with different dosages given for the first part and follow-up for the remaining period. Researchers will use blood tests and other checks to monitor the drug's effects and safety.
Popular Filters
Trials for Plaque Psoriasis Patients
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
TENS for Psoriasis Injection Pain
Recruiting1 award3 criteria
Winston-Salem, North Carolina
This trial is testing whether TENS therapy can reduce pain during and after the injection of biological medications. 10-20 subjects will be recruited and will receive the injection in one thigh with and one without the use of TENS therapy.
Trials for Psoriatic Arthritis Patients
Behavioral Intervention
Intermittent Fasting Diet for Psoriasis and Psoriatic Arthritis
Recruiting1 award5 criteria
Columbus, Ohio
This trial is studying whether intermittent fasting can improve psoriasis & PsA disease severity & quality of life. It will look at clinical parameters, biometric measurements, & quality of life indices. Results will help determine the role of IMF & other diets in psoriasis & provide dietary recommendations.
Phase 3 Trials
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
Monoclonal Antibodies
Subcutaneous Guselkumab for Psoriasis
Recruiting1 awardPhase 3
Palo Alto, California
This trial is testing a medication called guselkumab to see if it is safe and effective for children and teenagers with chronic plaque psoriasis. The medication aims to reduce inflammation and slow down the rapid growth of skin cells. Guselkumab is the first IL-23 specific inhibitor to be approved for the treatment of plaque psoriasis and has shown excellent safety and efficacy in previous studies.
Trials With No Placebo
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
TENS for Psoriasis Injection Pain
Recruiting1 award3 criteria
Winston-Salem, North Carolina
This trial is testing whether TENS therapy can reduce pain during and after the injection of biological medications. 10-20 subjects will be recruited and will receive the injection in one thigh with and one without the use of TENS therapy.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.